Study of PIG-U protein in breast cancer
Part of Cancer, Skin clinical trials.
This study looks at a protein called PIG-U in breast cancer tissue to understand its role in the disease. If you have breast cancer and haven't had chemotherapy or radiation yet, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with breast cancer (confirmed by biopsy and scans).
- You have not had any chemotherapy or radiation therapy for any cancer.
- You do not have another type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for circulating tumor cells—cancer cells that may travel in the blood—after standard breast cancer treatment, including chemotherapy before surgery and surgery itself. It may help doctors understand who might be at higher risk and tailor follow-up care.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This study looks at a specific gene called PCGEM1 in people newly diagnosed with breast cancer to understand how it affects the disease. Researchers hope this information will eventually help develop better treatments.
This study looks at a protein called IL-7 in the blood of women with breast cancer. It aims to find out if IL-7 levels can help doctors understand or track the disease better.
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.